🔎 Trials Near Me

Home › Cardiovascular Disease › Alabama

Cardiovascular Disease clinical trials in Alabama

22 studies for Cardiovascular Disease are looking for participants at sites in Alabama.

Cities in Alabama

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

  • Advanced Cardiovascular LLC, Alexander City
  • Cardiology, PC, Birmingham
  • Heart Center Research, LLC, Huntsville
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565

Adapting a Stress Management Intervention to Reduce Cardiovascular Disease Risk

  • University of Alabama at Birmingham, Birmingham
Recruiting
Ages 18 and older · Women · Updated Sep 28, 2026 · NCT06811896

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

  • Heart Center Research, LLC, Huntsville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07783802

Product Surveillance Registry

  • Birmingham
  • Huntsville
RecruitingObservational study
All ages · All sexes · Updated Sep 18, 2026 · NCT01524276

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  • Clinical Trial Site, Birmingham
  • Clinical Trial Site, Birmingham
  • Clinical Trial Site, Fairhope
  • and 4 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT07181109

Zenith® Fenestrated+ Clinical Study

  • University of Alabama Birmingham Hospital, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04875429

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Pinnacle Research Group, LLC, Anniston
  • Eastern Shore Research Group, Fairhope
  • Lakeview Clinical Research, Guntersville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07064473

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

  • University of Alabama Birmingham (UAB) Hospital, Birmingham
Recruiting
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT03242642

Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

  • University of Alabama at Birmingham Hospital, Birmingham
Recruiting
Ages 18 to 100 · All sexes · Updated Sep 9, 2026 · NCT06310031

An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  • SEC Clinical Research LLC, Andalusia
  • Heart Center Research Llc, Huntsville
  • Mobile Heart Specialists, Mobile
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT07517263

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • University of Alabama at Birmingham, Birmingham
  • Birmingham VA, Birmingham
RecruitingPhase 4Healthy volunteers welcome
Ages 75 and older · All sexes · Updated Sep 1, 2026 · NCT04262206

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

  • USA Health Strada Patient Care Center, Mobile
RecruitingObservational study
Ages 7 and older · All sexes · Updated Aug 25, 2026 · NCT05705531

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

  • Research Site, Athens
  • Research Site, Birmingham
  • Research Site, Birmingham
  • and 8 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

  • Advanced Cardiovascular LLC, Alexander City
  • University of Alabama Birmingham Saint Vincents Birmingham, Birmingham
  • Birmingham Clinical Research, Birmingham
  • and 4 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012

Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities

  • Cooper Green Mercy Hospital, Birmingham
RecruitingObservational study
Ages 50 to 99 · All sexes · Updated Aug 6, 2026 · NCT07748858

NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black Individuals

  • University of Alabama at Birmingham, Birmingham
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Jul 28, 2026 · NCT04055428

Pivotal Study for the Cardiac Performance System (CPS)

  • Huntsville Hospital Heart Center, Huntsville
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 24, 2026 · NCT06870591

GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

  • University of Alabama at Birmingham, Birmingham
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT05216042

PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm Axis

  • University of Alabama at Birmingham, Birmingham
RecruitingPhase 2/3Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 9, 2026 · NCT04971720

CARBON: UAB Cardiovascular Research Biobank

  • University of Alabama at Birmingham, Birmingham
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05067231

Inspire HER: Inspiring the Heart and Emotions for Radical Health

  • University of Alabama at Birmingham, Birmingham
Recruiting
Ages 30 to 79 · Women · Updated Dec 29, 2025 · NCT06966258

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

  • Cardiology, PC - Princeton Baptist Medical Center, Birmingham
Recruiting
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.